SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RNAi -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (203)3/28/2004 12:58:41 AM
From: tuck  Read Replies (1) | Respond to of 671
 
The Scientist with a fresh overview of RNAi therapeutics. Downplays the interferon response issue -- as this has not been seen in vivo -- though the off target effects issue lingers. Also explains why AMD and hepatitis are the first targets.

the-scientist.com

Cheers, Tuck